{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:37:32Z","timestamp":1777095452713,"version":"3.51.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202867"],"award-info":[{"award-number":["82202867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303246"],"award-info":[{"award-number":["82303246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ50493"],"award-info":[{"award-number":["2025JJ50493"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ41066"],"award-info":[{"award-number":["2023JJ41066"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ50543"],"award-info":[{"award-number":["2025JJ50543"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JJ50070"],"award-info":[{"award-number":["2021JJ50070"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.celrep.2026.116927","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:13:59Z","timestamp":1770243239000},"page":"116927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ESM1 SUMOylation mediates bevacizumab resistance in ovarian cancer through ITGB1-FAK-driven angiogenesis"],"prefix":"10.1016","volume":"45","author":[{"given":"Xiaomin","family":"Ran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4844-0520","authenticated-orcid":false,"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.116927_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188361","article-title":"Targeting tumor microenvironment in ovarian cancer: Premise and promise","volume":"1873","author":"Jiang","year":"2020","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.116927_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2478\/jtim-2023-0091","article-title":"Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism","volume":"11","author":"Dou","year":"2023","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","article-title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","volume":"86","author":"Schoutrop","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.celrep.2026.116927_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2478\/jtim-2024-0025","article-title":"Actin-related protein 2\/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT\/PI3K\/mTOR signaling pathway","volume":"12","author":"Ke","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib5","article-title":"Molecular Biomarkers for the Early Detection of Ovarian Cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.32604\/or.2024.049743","article-title":"Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review","volume":"32","author":"Cvetanovic","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.celrep.2026.116927_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.32604\/or.2024.031006","article-title":"Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review","volume":"32","author":"Alemzadeh","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.celrep.2026.116927_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: A review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.celrep.2026.116927_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.annonc.2023.05.005","article-title":"Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1\/ENGOT-ov25 trial","volume":"34","author":"Ray-Coquard","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2022.11.017","article-title":"Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population","volume":"180","author":"Casadei-Gardini","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.celrep.2026.116927_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","article-title":"Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.celrep.2026.116927_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41416-019-0725-x","article-title":"Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment","volume":"122","author":"Horikawa","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.116927_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2023.01.020","article-title":"Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FR\u03b1)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer","volume":"170","author":"Gilbert","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib14","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/fon-2019-0042","article-title":"Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer","volume":"16","author":"Haunschild","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ygyno.2019.03.246","article-title":"Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer","volume":"153","author":"Secord","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225681","article-title":"Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance","volume":"14","author":"Kang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.celrep.2026.116927_bib18","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.7150\/ijbs.100276","article-title":"ESM1 facilitates the EGFR\/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signaling","volume":"20","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3892\/or.2020.7913","article-title":"ESM1\/HIF-1\u03b1 pathway modulates chronic intermittent hypoxia-induced non-small-cell lung cancer proliferation, stemness and epithelial-mesenchymal transition","volume":"45","author":"Gu","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.celrep.2026.116927_bib20","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/1078-0432.CCR-19-0859","article-title":"ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma","volume":"25","author":"Calderaro","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib21","first-page":"2920","article-title":"ESM1 promotes angiogenesis in colorectal cancer by activating PI3K\/Akt\/mTOR pathway, thus accelerating tumor progression","volume":"15","author":"Yang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.celrep.2026.116927_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7150\/ijbs.66839","article-title":"Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061363","article-title":"ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells","volume":"12","author":"Jin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.celrep.2026.116927_bib24","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1111\/cas.15939","article-title":"Novel specific anti-ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis","volume":"114","author":"Kang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104126","article-title":"SUMOylation in Viral Replication and Antiviral Defense","volume":"9","author":"Fan","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202631119","article-title":"FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis","volume":"119","author":"Zhu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.116927_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152383","article-title":"Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer","volume":"132","author":"Demel","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.116927_bib28","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.3390\/ijms140611061","article-title":"Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro","volume":"14","author":"Dong","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib29","article-title":"SUMOylation Wrestles With the Occurrence and Development of Breast Cancer","volume":"11","author":"Qin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/thno.79688","article-title":"Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.celrep.2026.116927_bib31","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1002\/mco2.790","article-title":"Multifaceted role of TRIM28 in health and disease","volume":"5","author":"Maghsoudloo","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.celrep.2026.116927_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41418-025-01452-4","article-title":"Redox regulation of TRIM28 facilitates neuronal ferroptosis by promoting SUMOylation and inhibiting OPTN-selective autophagic degradation of ACSL4","volume":"32","author":"Liu","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2026.116927_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biochi.2022.10.006","article-title":"TRIM28 regulates transcriptional activity of methyl-DNA binding protein Kaiso by SUMOylation","volume":"206","author":"Lobanova","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.celrep.2026.116927_bib34","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.7150\/jca.86742","article-title":"A systematic pan-cancer analysis identifies TRIM28 as an immunological and prognostic predictor and involved in immunotherapy resistance","volume":"14","author":"Shang","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.celrep.2026.116927_bib35","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1038\/s41467-022-32061-1","article-title":"TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway","volume":"13","author":"Rossitto","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.116927_bib36","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1158\/2326-6066.CIR-21-0754","article-title":"The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity","volume":"9","author":"Lin","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2026.116927_bib37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s13402-024-00981-3","article-title":"TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation","volume":"47","author":"Xue","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jot.2024.06.015","article-title":"Sargassum polysaccharide attenuates osteoarthritis in rats and is associated with the up-regulation of the ITG\u03b21-PI3K-AKT signaling pathway","volume":"47","author":"Liu","year":"2024","journal-title":"J. Orthop. Translat."},{"key":"10.1016\/j.celrep.2026.116927_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304627","article-title":"3D Chiral Self-Assembling Matrixes for Regulating Polarization of Macrophages and Enhance Repair of Myocardial Infarction","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib40","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s13577-023-00983-7","article-title":"TRIM28 recruits E2F1 to regulate CBX8-mediated cell proliferation and tumor metastasis of ovarian cancer","volume":"36","author":"Zhang","year":"2023","journal-title":"Hum. Cell"},{"key":"10.1016\/j.celrep.2026.116927_bib41","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/1878-0261.70065","article-title":"Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis","volume":"19","author":"Leach","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13046-023-02862-3","article-title":"E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells","volume":"42","author":"Liang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib43","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/s41467-021-25033-4","article-title":"TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation","volume":"12","author":"Qin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.116927_bib44","doi-asserted-by":"crossref","first-page":"W238","DOI":"10.1093\/nar\/gkae346","article-title":"GPS-SUMO 2.0: an updated online service for the prediction of SUMOylation sites and SUMO-interacting motifs","volume":"52","author":"Gou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.116927_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3892\/ol.2024.14270","article-title":"Roles of endothelial cell specific molecule-1 in tumor angiogenesis","volume":"27","author":"Zhou","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.celrep.2026.116927_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.900082","article-title":"Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide","volume":"12","author":"Lodi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.116927_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2026.116927_bib48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41467-021-27944-8","article-title":"HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.116927_bib49","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMoa2214963","article-title":"Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer","volume":"388","author":"Prager","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib50","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMe2004851","article-title":"Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer","volume":"382","author":"Kelley","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103703","article-title":"Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials","volume":"174","author":"Nozawa","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.celrep.2026.116927_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12905-023-02329-9","article-title":"Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.celrep.2026.116927_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbae026","article-title":"Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K\/AKT signaling pathway","volume":"7","author":"Li","year":"2024","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-023-04819-8","article-title":"ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2026.116927_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112461","article-title":"Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8(+) T-cell response by activating the Wnt\/\u03b2-catenin pathway in ovarian cancer cells and inducing cisplatin resistance","volume":"137","author":"Fan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.celrep.2026.116927_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semcancer.2022.09.006","article-title":"Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1","volume":"86","author":"Lawler","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.celrep.2026.116927_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-024-03082-z","article-title":"CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006616","article-title":"Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer","volume":"12","author":"Gao","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.116927_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10456-020-09707-z","article-title":"Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS\/p53\/BAI1 signaling pathway","volume":"23","author":"Cao","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.celrep.2026.116927_bib61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cac2.12274","article-title":"The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells","volume":"42","author":"Wang","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.celrep.2026.116927_bib62","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41598-024-82400-z","article-title":"ESM1 promote proliferation, invasion and angiogenesis via Akt\/mTOR and Ras pathway in kidney renal clear cell carcinoma","volume":"15","author":"Luo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.116927_bib63","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.7150\/thno.95766","article-title":"Hypoxia-driven M2-polarized macrophages facilitate the epithelial-mesenchymal transition of glioblastoma via extracellular vesicles","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.celrep.2026.116927_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-023-01338-3","article-title":"Integrin\u03b2-1 in disorders and cancers: molecular mechanisms and therapeutic targets","volume":"22","author":"Su","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.celrep.2026.116927_bib65","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7150\/thno.77441","article-title":"ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer","volume":"13","author":"Sun","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.celrep.2026.116927_bib66","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41467-022-30105-0","article-title":"EZH2 engages TGF\u03b2 signaling to promote breast cancer bone metastasis via integrin \u03b21-FAK activation","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.116927_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101116","article-title":"A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis","volume":"76","author":"Guo","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.celrep.2026.116927_bib68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7150\/ijbs.52319","article-title":"ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib69","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1158\/0008-5472.CAN-13-0011","article-title":"\u03b21 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma","volume":"73","author":"Carbonell","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib70","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210050","article-title":"SUMOylation modification-mediated cell death","volume":"11","author":"Sheng","year":"2021","journal-title":"Open Biol."},{"key":"10.1016\/j.celrep.2026.116927_bib71","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/nar\/gkab065","article-title":"SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs","volume":"49","author":"Hou","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.116927_bib72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41392-023-01685-0","article-title":"SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer","volume":"8","author":"Diao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.116927_bib73","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12072-025-10779-6","article-title":"TRIM28 functions as SUMO ligase to SUMOylate TRAF6 and regulate NF-\u03baB activation in HBV-replicating cells","volume":"19","author":"Yang","year":"2025","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.celrep.2026.116927_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110354","article-title":"K48\/K63-linked polyubiquitination of ATG9A by TRAF6 E3 ligase regulates oxidative stress-induced autophagy","volume":"38","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.116927_bib75","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41419-023-06222-z","article-title":"The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.116927_bib76","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-024-07137-z","article-title":"TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth","volume":"15","author":"Xia","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.116927_bib77","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCRESAHA.123.323398","article-title":"SUMOylation Fine-Tunes Endothelial HEY1 in the Regulation of Angiogenesis","volume":"134","author":"Ren","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.celrep.2026.116927_bib78","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2026.116927_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415585","article-title":"The VEGF\/VEGFR Axis Revisited: Implications for Cancer Therapy","volume":"23","author":"Mabeta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib80","article-title":"SENP6-Mediated deSUMOylation of VEGFR2 Enhances Its Cell Membrane Transport in Angiogenesis","volume":"24","author":"He","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.116927_bib81","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1158\/0008-5472.CAN-23-0025","article-title":"Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases","volume":"83","author":"Zheng","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157399","article-title":"Targeting FAP\u03b1-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models","volume":"132","author":"Qi","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.116927_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101299","article-title":"Gamma-synuclein drives bevacizumab resistance in colorectal cancer via VEGFR2 activation and angiogenesis","volume":"84","author":"Liu","year":"2026","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.celrep.2026.116927_bib84","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1158\/1541-7786.MCR-23-0015","article-title":"Continuous Administration of Anti-VEGFA Antibody Upregulates PAI-1 Secretion from Ovarian Cancer Cells via miR-143-3p Downregulation","volume":"21","author":"Yagi","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.celrep.2026.116927_bib85","article-title":"S100B induces angiogenesis via the clathrin\/FOXO1\/\u03b2-catenin signaling pathway and contributes to Bevacizumab resistance in epithelial ovarian cancer","volume":"1232","author":"Xu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.celrep.2026.116927_bib86","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.4103\/0973-1482.204896","article-title":"Resistance to bevacizumab in ovarian cancer SKOV3 xenograft due to EphB4 overexpression","volume":"15","author":"Li","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.celrep.2026.116927_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.955984","article-title":"Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44\/CD117 in human ovarian cancer SKOV3 cells","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:52:26Z","timestamp":1777092746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2211124726000057"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.116927","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESM1 SUMOylation mediates bevacizumab resistance in ovarian cancer through ITGB1-FAK-driven angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.116927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116927"}}